MARIA IFTIKHAR: Open Payments
NPI 1053972190 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 38 payments from 14 companies in 2025. Trend: 2023 $883 · 2024 $712 · 2025 $769
Food & beverage: $744Education: $25
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $195 |
| Novo Nordisk Inc | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Lilly USA, LLC | 2 | $45 |
| Cleerly, Inc. | 1 | $40 |
| PFIZER INC. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Ozempic, VRAYLAR, QULIPTA, AIRSUPRA, MOUNJARO, Wegovy, Cleerly Ischemia, Veozah.
Industry payments across VA — which companies pay providers there.
